HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.

WCID 2026

Anant Marathe, Speaker at Infection Conferences
Keynote Presentation (In-person)
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India

Background: Non tuberculous bacteria (NTM) are increasingly recognised cause of pulmonary as well as extrapulmonary infection worldwide. This rising prevalence of NTM, particularly rapidly growing mycobacteria along with their inherent and acquired drug resistance, and species-sp [....] » Read More

Michel Bellaiche, Speaker at Infectious Disease Conference
Oral Presentation (In-person)
Michel Bellaiche, Kimron Veterinary Institute, Israel

Background: West Nile Virus (WNV) is a well-established flavivirus endemic to Israel, maintained in an enzootic cycle between Culex spp. mosquitoes and avian reservoirs, with humans and equines serving as incidental "dead-end" hosts. While approximately 80% of human inf [....] » Read More

Pablo Daniel Roque, Speaker at Infection Conferences
Oral Presentation (In-person)
Pablo Daniel Roque, Municipality of San Carlos de Bariloche, Argentina

Urban companion animals play a significant role in the epidemiology of several infectious and zoonotic diseases. In many cities, unequal access to veterinary services and insufficient population control strategies may contribute to the persistence of zoonotic risks. Strengthening [....] » Read More

Wenli Cao, Speaker at Infectious Diseases Conferences
Oral Presentation (In-person)
Wenli Cao, Beijing Geriatric Hospital, China

The obstructive pulmonary disease tuberculosis B (tuberculosis obstructive pulmonary called TOPD disease) in elderly patients with tuberculosis is a common and early prevention and treatment, the latter to irreversible persistent airflow limitation and accompanied by chronic airw [....] » Read More

Liu Yan, Speaker at Infectious Diseases Conferences
Oral Presentation (In-person)
Liu Yan, Ruijin Hospital, China

Background: Severe viral pneumonias, particularly those caused by influenza A virus, respiratory syncytial virus (RSV), and emerging coronaviruses, continue to pose formidable challenges to global public health. While Interferon-alpha (IFN-α) remains a cornerstone of a [....] » Read More

Liu Yan, Speaker at Infectious Diseases Conferences
Oral Presentation (In-person)
Liu Yan, Ruijin Hospital, China

Background: Severe viral pneumonias (e.g.,influenza, RSV) lack effective localized treatments.While Interferon-α (IFN-α) is a potent antiviral, its clinical utility via inhalation is limited by rapid degradation, poor lung retention, and systemic toxicity. We dev [....] » Read More

Achut Babu Ojha, Speaker at Infectious Diseases Conferences
Oral Presentation (In-person)
Achut Babu Ojha, Om Sterling Global University, India

Background: Lymphatic filariasis (LF), commonly known as elephantiasis, is a debilitating mosquito-borne disease caused by filarial parasites. The Global program to Eliminate to Lymphatic Filariasis was launched by WHO in 2000 with the aim of eliminating lymphatic filariasis as a [....] » Read More

Sushil Kumar Choudhary, Speaker at Infection Conferences
Oral Presentation (In-person)
Sushil Kumar Choudhary, All India Institute of Medical Sciences (AIIMS) Jodhpur, India

Background: Neonatal sepsis is a significant cause of morbidity and mortality in low- and middle-income countries. Timely and accurate diagnosis of neonatal sepsis continues to be a major clinical challenge. The study aims to determine whether sequential cultures improve pat [....] » Read More

Refat Sadeq, Speaker at Infectious Diseases Conferences
Oral Presentation (In-person)
Refat Sadeq, Portsaid University, Egypt

As a serious side effect of infections (such as meningitis or pneumonia), during surgery (particularly when mucous membranes are involved, like in the gastrointestinal tract), or when catheters and other foreign objects get into the arteries or veins (including during intravenous [....] » Read More

Som Dipielte Estelle Mireille, Speaker at Infection Conferences
Oral Presentation (In-person)
Som Dipielte Estelle Mireille, Angré University Hospital, Cote d'Ivoire

Background: The emergence of multidrug-resistant strains of Mycobacterium tuberculosis (MTB) represents a global public health challenge. The challenge in managing tuberculosis lies in the rapid diagnosis of these resistances. The objective of this study was to determine the prop [....] » Read More

Temesgen Kabeta Chala, Speaker at Infection Conferences
Oral Presentation (In-person)
Temesgen Kabeta Chala, Jimma University, Ethiopia

Background: Despite widely available and effective treatment, leprosy remains a major public health issue in Ethiopia. The disease is often misconstrued as a hereditary disease in origin, a curse, or a form of divine punishment for immoral behavior. In this study, we aim to explo [....] » Read More

Malik Olatunde Oduoye, Speaker at Infection Conferences
Oral Presentation (In-person)
Malik Olatunde Oduoye, The Medical Research Circle (MedReC), Nigeria

Background: Measles elimination in the United States in 2000 was achieved through widespread vaccination and the adoption of the two-dose schedule. However, outbreaks since 2014 reveal how biomedical gains can be reversed when social and digital dynamics undermine vaccine up [....] » Read More

Sohyun Park, Speaker at Infection Conferences
Oral Presentation (In-person)
Sohyun Park, Busan Metropolitan City Institute of Health and Environment, Korea, Republic of

Carbapenem-resistant Enterobacterales (CRE) have emerged as a major global public health threat due to limited therapeutic options and high mortality rates, particularly in bloodstream infections. Regional epidemiological data are essential for understanding the dissemination of [....] » Read More

Shiva Kashyap Yellavajhala, Speaker at Infectious Diseases Conferences
Oral Presentation (In-person)
Shiva Kashyap Yellavajhala, Amity University, India

The 21st century’s most urgent global health challenge is Antimicrobial resistance (AMR) as it is predicted that AMR will lead to 10 million deaths every year by 2050. However, the conventional diagnostic approaches take 48 to 72 hours to yield results leading to a dangerou [....] » Read More

Haftay Abraha Tadesse, Speaker at Infectious Diseases Conferences
Oral Presentation (In-person)
Haftay Abraha Tadesse, Mekelle University, Ethiopia

Background: Oropharyngeal candidiasis (OPC) is the most common opportunistic infection encountered among human immunodeficiency virus-infected patients and is considered an independent predictor of immunodeficiency in patients with acquired immunodeficiency syndrome (AIDS). Thoug [....] » Read More

Ajiji Azi, Speaker at Infectious Diseases Conferences
Oral Presentation (In-person)
Ajiji Azi, University of Jos, Nigeria

Statement of Problem: Parasite control programs that rely on mass drug administration (MDA) over prolonged periods using the same antihelmintic drugs would exert selection pressure on hookworm populations and favour the development of drug resistance. Benzimidazole resistance in [....] » Read More

Shahreen Islam Raisa, Speaker at Infectious Disease Conference
Poster Presentation (In-person)
Shahreen Islam Raisa, The Grand Rehabilitation and Nursing, United States

Aim: Linezolid (LZD) is an oxazolidinone antibiotic with potent activity against methicillin-resistant Staphylococcus aureus (MRSA). While thrombocytopenia is a recognized side effect, concurrent anemia leading to bicytopenia is less frequently documented. The aim of this study i [....] » Read More

Neelesh Sathish, Speaker at Infection Conferences
Poster Presentation (In-person)
Neelesh Sathish, South Windsor High School, United States

Flaviviruses such as Zika and Powassan virus can cause serious neurological disease because they are able to cross protective barriers in the body including the blood brain barrier and the placenta. This allows the virus to infect the brain and developing fetus, leading to condit [....] » Read More

Shivadarshini Ramachandran, Speaker at Infectious Diseases Conferences
Poster Presentation (In-person)
Shivadarshini Ramachandran, Northumbria University, United Kingdom

Bloodstream infections, particularly in sepsis, need fast and accurate pathogen identification. Although culture-based diagnostics remain the gold standard, they are limited by delayed results, contamination risk and low sensitivity in low-biomass or polymicrobial infections. [....] » Read More

Yu Chen Wu, Speaker at Infectious Diseases Conferences
Poster Presentation (In-person)
Yu Chen Wu, The University of Queensland, Australia

Background: Human hookworm infection, primarily caused by the hematophagous nematode Necator americanus, remains a leading neglected tropical disease (NTD) characterized by chronic iron-deficiency anaemia and malnutrition. While current anthelmintic drug treatments provide tempor [....] » Read More

Yujeong Na, Speaker at Infection Conferences
Poster Presentation (In-person)
Yujeong Na, Daewoong Pharmaceutical Co., Ltd, Korea, Republic of

Antiviral activity was demonstrated in human nasal epithelial cells and a mouse influenza model. The formulation inhibited viral entry in vitro and suppressed TMPRSS2 expression in vivo, a key factor for viral penetration. Cytotoxicity tests confirmed no toxicity, following ISO 1 [....] » Read More

Mahmoud Mohamed, Speaker at Infectious Disease Conference
Poster Presentation (In-person)
Mahmoud Mohamed, Ministry of Municipality, Qatar

In 2024, a total of 1,333 roaming dogs were sampled across Qatar to estimate their population size and test for rabies. Surveyed areas were randomly selected to ensure representation across all municipalities and zones, encompassing 419 of 4,000 total blocks. A portable laborator [....] » Read More

Martha Mercado, Speaker at Infectious Diseases Conferences
Poster Presentation (In-person)
Martha Mercado, UNAM, Mexico

Background: The potential of wastewater-based epidemiology (WBE) as a surveillance and early warning tool for the COVID-19 outbreak and antimicrobial resistance has been demonstrated in numerous publications. Since WBE is an emerging research area, connecting wastewater data t [....] » Read More

Sayantani Datta, Speaker at Infectious Disease Conference
Poster Presentation (In-person)
Sayantani Datta, Indian Institute of Technology Kharagpur, India

Coronin-1 (Cor1), also known as p57 or TACO (for Tryptophan Aspartate containing Coat protein), a highly conserved WD-repeat protein enriched in immune cells, orchestrates host–pathogen interactions and immune signalling; yet the molecular circuitry controlling its transcri [....] » Read More

Debayan Das, Speaker at Infection Conferences
Poster Presentation (In-person)
Debayan Das, Indian Institute of Technology Kharagpur, India

Tuberculosis remains one of the world’s deadliest and most persistent infectious diseases, caused by Mycobacterium tuberculosis (M.tb). Among its key virulence determinants, ESAT-6 (Early Secreted Antigenic Target-6) is a secreted protein widely recognized for its potent im [....] » Read More

Yassein M Ibrahim, Speaker at Infectious Disease Conference
Poster Presentation (In-person)
Yassein M Ibrahim, Chinese Academy of Agricultural Sciences, China

Background: Parainfluenza virus 5 (PIV5), is a negative‐sense, non-segmented, single‐stranded RNA virus a member of the Paramyxoviridae family, causes respiratory and neurological infection in several animal species. Whereas information on PIV5 infection in digestive system i [....] » Read More

Emmanuel Joseph M Mamaril, Speaker at Infectious Disease Conference
Poster Presentation (In-person)
Emmanuel Joseph M Mamaril, National Kidney and Transplant Institute, Philippines

Introduction: Invasive fungal infections comprise a group of diseases affecting deep-seated tissues, with the most common etiologic agents being Candida and Aspergillus species. These are associated with high morbidity and mortality. Populations commonly affected are those in imm [....] » Read More

Fauzio Nurul Khaira, Speaker at Infectious Diseases Conferences
Poster Presentation (In-person)
Fauzio Nurul Khaira, Andalas University, Indonesia

Background: Sepsis remains a major cause of morbidity and mortality in critically ill patients worldwide due to dysregulated host responses leading to multiorgan dysfunction. Early identification of patients with severe organ failure is essential to improve prognosis and optimize [....] » Read More

Rohayat Bilmahdi, Speaker at Infectious Disease Conference
Poster Presentation (In-person)
Rohayat Bilmahdi, University of Indonesia, Indonesia

Background: Early mortality prediction in sepsis remains challenging because of the complex interaction between tissue hypoperfusion, organ dysfunction, and systemic inflammation. Conventional prognostic tools such as serum lactate and Sequential Organ Failure Assessment (SO [....] » Read More

Imen Larbi, Speaker at Infectious Diseases Conferences
Poster Presentation (In-person)
Imen Larbi, Pasteur Institute of Tunis, Tunisia

West Nile virus (WNV) is an arthropod borne virus, the most widely distributed of the encephalitic Orthoflaviviruses. It can cause severe neurological symptoms in both humans and horses. It poses an emerging threat to both public and animal health. In this study, we retrospective [....] » Read More

Priscilla Suleman Johnstone, Speaker at Infection Conferences
Poster Presentation (In-person)
Priscilla Suleman Johnstone, Blantyre Malaria Project, Malawi

Introduction: Malaria remains a major cause of morbidity and mortality in endemic regions, including Malawi. The ABO blood group system has been proposed as a genetic factor influencing disease severity. Evidence suggests that blood group O may confer relative protection against [....] » Read More

Chuchu Churko, Speaker at Infectious Disease Conference
Poster Presentation (In-person)
Chuchu Churko, Arba Minch University, Ethiopia

Background: Visceral leishmaniasis (VL) is a severe, infectious, life-threatening public health concern in Ethiopia. Since early 2022, the outbreak of VL in the South Omo Zone, particularly among pastoralist communities, has resulted in multiple deaths. Objective: To assess th [....] » Read More

Nguena Guefack Noumedem Ranyl, Speaker at Infectious Diseases Conferences
Poster Presentation (In-person)
Nguena Guefack Noumedem Ranyl, National Veterinary Laboratory , Cameroon

Introduction/Background: Antimicrobial resistance (AMR) integrated surveillance approach is helpful to understand the drivers and complexity of AMR at the human-animal-plant and environmental interface, and to guide policy and decision making for better mitigation of the risk on [....] » Read More

Toure Amidou, Speaker at Infectious Disease Conference
Poster Presentation (In-person)
Toure Amidou, Angre University Hospital Center, Cote d'Ivoire

Background: Viral hepatitis B (HBV) and C (HCV) remain major global public health challenges, particularly in sub-Saharan Africa. In Côte d’Ivoire, a high-endemicity area, updating epidemiological data is crucial to guide national response strategies in accordance wit [....] » Read More

Silviya Stoyanova, Speaker at Infectious Disease Conference
Poster Presentation (In-person)
Silviya Stoyanova, Military Medical Academy Sofia, Bulgaria

Actinomycosis is a rare, chronic purulent disease caused by Actinomyces spp, anaerobic gram-positive bacteria. Actinomycosis usually infects patients with a compromised mucosal barrier and in most cases occurs after surgery, trauma, neoplasia, dental procedures, aspiration of sec [....] » Read More

Francis J Castellino, Speaker at Infection Conferences
Keynote Presentation (Virtual)
Francis J Castellino, University of Notre Dame, United States

The molecular and cellular communication between the host and pathogen is critical to survival of both organisms after Group A Streptcoccus pyogenes (GAS) infection.  After attachment and invasion of the pathogen, the human host employs its innate immune system to ward off t [....] » Read More

Ranjan Ramasamy, Speaker at Infectious Diseases Conferences
Keynote Presentation (Virtual)
Ranjan Ramasamy, IDFISH Technology, United States

The changing state of protective immunity to COVID-19 in the global population during the time since COVID-19’s origin in 2019 is analysed in the context of the (i) circulation of SARS-CoV-2 in the population, (ii) widespread use of different types of COVID-19 vaccines [....] » Read More

Reza Nassiri, Speaker at Infectious Diseases Conferences
Keynote Presentation (Virtual)
Reza Nassiri, Michigan State University, United States

The CDC classifies C. auris as an urgent antimicrobial resistance threat, the highest level of concern due to its resistance to multiple antifungal drugs and the ease of transmission in healthcare settings. The WHO places it in the critical priority group of fungal pathogens. C. [....] » Read More

Saurabh Chattopadhyay, Speaker at Infection Conferences
Keynote Presentation (Virtual)
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States

The interferon (IFN) system is a critical first-line defense against viral infection, orchestrating antiviral programs while shaping early inflammatory responses. Although inflammation is essential for pathogen control, dysregulated cytokine production is a major driver of morbid [....] » Read More

Ranjan Ramasamy, Speaker at Infectious Diseases Conferences
Oral Presentation (Virtual)
Ranjan Ramasamy, IDFISH Technology, United States

The nasal cavity has an important physiological role in warming and humidifying inspired air before the it enters the nasopharynx and trachea. This process has been termed nasal air conditioning. Nasal structures vary geographically, and have been correlated with the varying need [....] » Read More

Richard Dembo, Speaker at Infectious Diseases Conferences
Oral Presentation (Virtual)
Richard Dembo, University of South Florida, United States

Youth involved in the juvenile justice system remain a significantly underserved population at markedly elevated risk for multiple problems, including traumatizing experiences, substance misuse, mental health, and sexually transmitted diseases.     A “tr [....] » Read More

Patricia Tai, Speaker at Infection Conferences
Oral Presentation (Virtual)
Patricia Tai, University of Saskatchewan, Canada

Background: Cancer patients are at heightened risk of infections due to immunosuppression from chemotherapy, radiotherapy, stem cell transplantation, and the underlying malignancy itself. These infections contribute significantly to morbidity, mortality, and healthcare costs. Und [....] » Read More

Ekaterina Zueva, Speaker at Infectious Disease Conference
Oral Presentation (Virtual)
Ekaterina Zueva, Lomonosov Moscow State University, Russian Federation

The article provides a comprehensive review of the epizootic and epidemiological situation regarding highly pathogenic avian influenza (HPAI) in Russia from 2003 to 2024. It examines the ecological characteristics of the pathogen, transmission routes and factors, and the signific [....] » Read More

Deresse Daka, Speaker at Infectious Diseases Conferences
Oral Presentation (Virtual)
Deresse Daka, 2Hawassa University College of Medicine and Health Sciences, Ethiopia

Background: Tuberculosis is a major global health crisis, with conflicts and displacement dramatically increasing its risk and spread. Conflicts disrupt healthcare, leading to overcrowded, unsanitary conditions, accelerating tuberculosis spread, particularly among displaced popul [....] » Read More

K M Yacob , Speaker at Infection Conferences
Oral Presentation (Virtual)
K M Yacob , Marma Health Centre, India

Fever is one of the least knowledgeable topics in modern science. Looking at medical journals and medical books, modern science does not even know the basic facts about fever. Modern science does not know what the purpose of fever is, what fever is, what to do to get a feve [....] » Read More

K M Yacob , Speaker at Infection Conferences
Oral Presentation (Virtual)
K M Yacob , Marma Health Centre, India

No medical textbook tells us what the purpose of fever is. Without knowing this, no one in the world can define, test, or treat fever. The current definition, testing, and treatment of fever, which is constructed without knowing what the purpose of fever is, has no scientific bas [....] » Read More

Aishwarika Mitra, Speaker at Infectious Disease Conference
Oral Presentation (Virtual)
Aishwarika Mitra, Christ University, India

Dengue fever has been a prominent public health issue in India because it propagates quickly, it is seasonal, and it recurs, which shows its powerful characteristic as a vector-borne disease. This paper is a detailed statistical data analysis of dengue incidence and mortality i [....] » Read More

Suleiman Kawu, Speaker at Infectious Disease Conference
Oral Presentation (Virtual)
Suleiman Kawu, Gombe State University, Nigeria

Introduction: Malaria test positivity rate (TPR) is a key surveillance indicator recommended by the World Health Organization to monitor transmission intensity. Subnational analyses using routine primary health care (PHC) laboratory data are limited in North-East Nigeria. This st [....] » Read More

Isaac Bakare, Speaker at Infection Conferences
Oral Presentation (Virtual)
Isaac Bakare, General Hospital Odan, Nigeria

Background: HIV and antiretroviral therapy (ART) can significantly impact hematological, hepatic and renal functions, although the effects are complex and influenced by factors including type of drugs, duration of therapy and patients’ underlying conditions. However, the in [....] » Read More

Prasanth Chandrasekhar Bhat, Speaker at Infectious Disease Conference
Poster Presentation (In-person)
Prasanth Chandrasekhar Bhat, Tata Memorial Centre, India

Background: Burkholderia cepacia complex (BCC) is a non-fermenting Gram-negative bacillus known for its ability to survive in aqueous environments, disinfectants, and medical solutions. It is an opportunistic pathogen that poses significant risk to immunocompromised pat [....] » Read More

Atul Garg, Speaker at Infection Conferences
Poster Presentation (In-person)
Atul Garg, Sanjay Gandhi Postgraduate Institute of Medical Sciences, India

Background: Acute flaccid paralysis (AFP), characterized by the rapid onset of asymmetric paralysis, can be caused by a variety of viral infections or coinfections. The clinical manifestations range from conjunctivitis, respiratory tract infection, myocarditis, meningitis, e [....] » Read More

Alvin Arif, Speaker at Infection Conferences
Poster Presentation (In-person)
Alvin Arif, Andalas University, Indonesia

Background: Single-point biomarkers may not adequately reflect disease progression in sepsis. Serial monitoring of biomarkers may improve early risk stratification. Proenkephalin (PENK), a novel biomarker associated with renal dysfunction and organ failure, may provide prognostic [....] » Read More

Ainur Zh Kussainova, Speaker at Infection Conferences
Poster Presentation (In-person)
Ainur Zh Kussainova, Kazakh National medical university, Kazakhstan

Background: The Republic of Kazakhstan is intensifying efforts to achieve the UNAIDS 95-95-95 targets as part of its national strategy to end the HIV/AIDS epidemic by 2030. According to national data, the HIV care continuum cascade among people living with HIV (PLHIV) in 202 [....] » Read More

Surendra Gaire, Speaker at Infectious Disease Conference
Poster Presentation (In-person)
Surendra Gaire, Lumbini Province, Nepal

Background: Scrub typhus, caused by Orientia tsutsugamushi, typically presents with acute fever and a pathognomonic black eschar. However, emerging atypical clinical profiles pose diagnostic dilemmas. This study outlines an unusual clinical spectrum of scrub typhus character [....] » Read More

Pooja Bagdi, Speaker at Infection Conferences
Poster Presentation (Virtual)
Pooja Bagdi, Trinity Educational Institute, India

Artificial intelligence (AI) has emerged as a powerful tool in modern healthcare, particularly in improving diagnostic accuracy and clinical decision-making. One of the major challenges in infectious disease management is the differentiation between viral and bacterial infections [....] » Read More

Scientific Programs coming soon..

Youtube
Watsapp